valproic acid and ubiquinone

valproic acid has been researched along with ubiquinone in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, S; Braunstein, D; Casadonte, P; Hitzemann, R; Majewska, D; Montgomery, A; Reid, MS; Robinson, J; Rotrosen, J; Sanfilipo, M	1
Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G	1
Fu, H; Jiang, G; Ju, X; Sun, X	1

Trials

1 trial(s) available for valproic acid and ubiquinone

Article	Year
A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence. Addiction (Abingdon, England), 2005, Volume: 100 Suppl 1 Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepines; Carnitine; Cocaine-Related Disorders; Coenzymes; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Ubiquinone; Valproic Acid	2005

Article

Year

A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence.

Addiction (Abingdon, England), 2005, Volume: 100 Suppl 1

Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepines; Carnitine; Cocaine-Related Disorders; Coenzymes; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Ubiquinone; Valproic Acid

2005

Other Studies

2 other study(ies) available for valproic acid and ubiquinone

Article	Year
Antimyoclonic effect of levetiracetam in MERRF syndrome. Journal of the neurological sciences, 2006, Apr-15, Volume: 243, Issue:1-2 Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Humans; Levetiracetam; MERRF Syndrome; Middle Aged; Mitochondria; Muscle, Skeletal; Mutation; Myoclonus; Phenylalanine; Piracetam; Quality of Life; RNA, Transfer; Treatment Outcome; Ubiquinone; Valproic Acid	2006
MELAS and macroangiopathy: A case report and literature review. Medicine, 2018, Volume: 97, Issue:52 Topics: Acidosis, Lactic; Adult; Arginine; Ascorbic Acid; Carotid Stenosis; Humans; Male; MELAS Syndrome; Mitochondrial Encephalomyopathies; Point Mutation; Ubiquinone; Valproic Acid	2018

Article

Year

Antimyoclonic effect of levetiracetam in MERRF syndrome.

Journal of the neurological sciences, 2006, Apr-15, Volume: 243, Issue:1-2

Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Humans; Levetiracetam; MERRF Syndrome; Middle Aged; Mitochondria; Muscle, Skeletal; Mutation; Myoclonus; Phenylalanine; Piracetam; Quality of Life; RNA, Transfer; Treatment Outcome; Ubiquinone; Valproic Acid

2006

MELAS and macroangiopathy: A case report and literature review.

Medicine, 2018, Volume: 97, Issue:52

Topics: Acidosis, Lactic; Adult; Arginine; Ascorbic Acid; Carotid Stenosis; Humans; Male; MELAS Syndrome; Mitochondrial Encephalomyopathies; Point Mutation; Ubiquinone; Valproic Acid

2018